# Anti-inflammatory Cells in Peritoneal Cavity

> **NCT03189316** · NA · TERMINATED · sponsor: **University Hospital, Montpellier** · enrollment: 10 (actual)

## Conditions studied

- Ovarian Cysts
- Chronic Renal Insufficiency

## Interventions

- **OTHER:** peritoneal fluid and blood sample

## Key facts

- **NCT ID:** NCT03189316
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-06
- **Primary completion:** 2017-12-13
- **Final completion:** 2017-12-13
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Absence of BReg Lymphocytes in peritoneum
- **Last updated:** 2018-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03189316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03189316, "Anti-inflammatory Cells in Peritoneal Cavity". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03189316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*